Analyst Profile

Followed by 2,608 followers
.
David Windley

David Windley

Jefferies
Wall Street Analyst
#94 out of 8,141 Wall Street Analysts
#176 out of 24,284 experts

Success Rate

68%
269 out of 393 transactions made a profit

Average Return

+14.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying David Windley's trades since 2009 and holding each position for 1 Year would result in 68.45% of your transactions generating a profit, with an average return of 14.2% per rating.

Stock Rating Distribution

942Ratings
60.08% Buy
38.85% Hold
1.06% Sell
Distribution of David Windley's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Hms (HMSY)
(HMSY)
Rating:Buy
Date:Aug 10, 2015 - Aug 10, 2016
Return:+153.00%
The most profitable rating made by David Windley

David Windley's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
WCRX
Warner Chilcott
Aug 25, 2009
Buy
Upgraded
1Ratings
0.00%
Alkermes
Aug 27, 2009
Hold
Downgraded
$11.50
(-52.48% Downside)
1Ratings
0.00%
PPDI
Pharmaceutical Product Development
Dec 14, 2009
Buy
Upgraded
1Ratings
0.00%
AGP
AmeriGroup
Jul 11, 2012
Hold
Downgraded
1Ratings
0.00%
CVH
Coventry Health Care
Feb 12, 2013
Hold
Reiterated
3Ratings
0.00%
CVD
Covance Inc
Nov 07, 2014
Hold
Downgraded
8Ratings
100%
+1.80%
WX
WuXi PharmaTech
Nov 21, 2014
Hold
Downgraded
8Ratings
0.00%
~ATHN
Athenahealth
Apr 14, 2015
Hold
Reiterated
7Ratings
0.00%
HNT
Health Net
Jul 15, 2015
Hold
Downgraded
13Ratings
100%
+35.65%
MGLN
Magellan Health
Aug 02, 2016
Buy
Reiterated
1Ratings
100%
+16.10%
List of latest recommendations made by David Windley. Click to expand and see David Windley's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >